FP

Flagship Pioneering Portfolio holdings

AUM $268M
This Quarter Return
-33.41%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$4.26B
AUM Growth
+$4.26B
Cap. Flow
+$16.2M
Cap. Flow %
0.38%
Top 10 Hldgs %
99.18%
Holding
13
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

1
AXLA
Axcella Health Inc. Common Stock
AXLA
$16.2M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRNA icon
1
Moderna
MRNA
$9.37B
$3.03B 71.11%
17,581,016
– –
SANA icon
2
Sana Biotechnology
SANA
$777M
$283M 6.64%
34,239,018
– –
RUBY
3
DELISTED
Rubius Therapeutics, Inc
RUBY
$212M 4.98%
38,506,526
– –
FHTX icon
4
Foghorn Therapeutics
FHTX
$286M
$193M 4.53%
12,674,120
– –
OMGA
5
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$162M 3.8%
25,902,269
– –
MCRB icon
6
Seres Therapeutics
MCRB
$166M
$102M 2.4%
14,378,802
– –
DNLI icon
7
Denali Therapeutics
DNLI
$2.23B
$84.3M 1.98%
2,619,968
– –
EVLO
8
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$78.1M 1.83%
23,030,069
– –
AXLA
9
DELISTED
Axcella Health Inc. Common Stock
AXLA
$48.5M 1.14%
18,867,785
+6,319,371
+50% +$16.2M
KLDO
10
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$32.3M 0.76%
19,575,710
– –
CDAK
11
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$16.3M 0.38%
2,607,303
– –
SGTX
12
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$15.2M 0.36%
10,370,369
– –
SYRS
13
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$3.5M 0.08%
2,938,494
– –